Bridgeway Capital Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.48K | Hold |
|
|||||
|
2025
Q2 | $5.55K | Sell |
|
|||||
|
2025
Q1 | $50.7K | Sell |
|
|||||
|
2024
Q4 | $273K | Sell |
|
|||||
|
2024
Q3 | $496K | Hold |
|
|||||
|
2024
Q2 | $526K | Hold |
|
|||||
|
2024
Q1 | $782K | Sell |
|
|||||
|
2023
Q4 | $1.06M | Hold |
|
|||||
|
2023
Q3 | $853K | Hold |
|
|||||
|
2023
Q2 | $1.09M | Hold |
|
|||||
|
2023
Q1 | $833K | Sell |
|
|||||
|
2022
Q4 | $619K | Sell |
|
|||||
|
2022
Q3 | $699K | Sell |
|
|||||
|
2022
Q2 | $1.02M | Buy |
|
|||||
|
2022
Q1 | $1.4M | Sell |
|
|||||
|
2021
Q4 | $2.81M | Sell |
|
|||||
|
2021
Q3 | $3M | Hold |
|
|||||
|
2021
Q2 | $3.58M | Buy |
|
|||||
|
2021
Q1 | $1.86M | Sell |
|
|||||
|
2020
Q4 | $1.75M | Sell |
|
|||||
|
2020
Q3 | $1.67M | Sell |
|
|||||
|
2020
Q2 | $1.95M | Buy |
|
|||||
|
2020
Q1 | $1.38M | Sell |
|
|||||
|
2019
Q4 | $1.97M | Hold |
|
|||||
|
2019
Q3 | $1.99M | Buy |
|
|||||
|
2019
Q2 | $1.08M | Sell |
|
|||||
|
2019
Q1 | $2.6M | Sell |
|
|||||
|
2018
Q4 | $2.03M | Buy |
|
|||||
|
2018
Q3 | $3.25M | Sell |
|
|||||
|
2018
Q2 | $4.12M | Hold |
|
|||||
|
2018
Q1 | $3.85M | Sell |
|
|||||
|
2017
Q4 | $2.76M | Buy |
|
|||||
|
2017
Q3 | $2.95M | Buy |
|
|||||
|
2017
Q2 | $1.8M | Buy |
|
|||||
|
2017
Q1 | $1.34M | Buy |
|
|||||
|
2016
Q4 | $1.13M | Buy |
|
|||||
|
2016
Q3 | $691K | Buy |
|
|||||
|
2016
Q2 | $718K | Hold |
|
|||||
|
2016
Q1 | $758K | Hold |
|
|||||
|
2015
Q4 | $871K | Buy |
|
|||||
|
2015
Q3 | $760K | Sell |
|
|||||
|
2015
Q2 | $1.15M | Hold |
|
|||||
|
2015
Q1 | $1.17M | Buy |
|
|||||
|
2014
Q4 | $1.14M | Hold |
|
|||||
|
2014
Q3 | $823K | Hold |
|
|||||
|
2014
Q2 | $915K | Hold |
|
|||||
|
2014
Q1 | $953K | Hold |
|
|||||
|
2013
Q4 | $945K | Sell |
|
|||||
|
2013
Q3 | $1.06M | Buy |
|
|||||
|
2013
Q2 | $939K | Buy |
|